ATA-200 Gene Therapy Trial in Patients With LGMDR5
Clinical trial NCT05973630 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05973630
- Sponsor
- Atamyo Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-15
- Primary completion
- 2026-10-30
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.